- Supplement Facts
- Usage Guide
A proprietary and patented strain of Saccharomyces cerevisiae CNCM I-3856.
This strain of S. cerevisiae has been used in human clinical trials in which it significantly controlled C. albicans proliferation and decreased the risk of recurrence by 54% compared to placebo.
Clinically researched for its inhibitory effects on C. albicans and G vaginalis
S. cerevisiae CNCM I-3856 has been researched for it’s inhibitory effect on pathogenic bacteria associated with candida
Rebalances the Microbiome
S. cerevisiae CNCM I-3856 has been shown in studies to support the rebalancing of the microbiome
Take 1 capsule daily.